Bio Solution Co.,Ltd. (KOSDAQ:086820)

Bio Solution Statistics

Total Valuation

Bio Solution has a market cap or net worth of KRW 216.76 billion. The enterprise value is 235.57 billion.

Market Cap	216.76B
Enterprise Value	235.57B

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Bio Solution has 25.80 million shares outstanding. The number of shares has increased by 3.91% in one year.

Current Share Class	25.80M
Shares Outstanding	25.80M
Shares Change (YoY)	+3.91%
Shares Change (QoQ)	+12.03%
Owned by Insiders (%)	17.71%
Owned by Institutions (%)	0.00%
Float	21.23M

Valuation Ratios

The trailing PE ratio is 792.93.

PE Ratio	792.93
Forward PE	n/a
PS Ratio	14.26
PB Ratio	6.77
P/TBV Ratio	6.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	861.77
EV / Sales	15.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-157.41

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.97.

Current Ratio	0.57
Quick Ratio	0.53
Debt / Equity	0.97
Debt / EBITDA	n/a
Debt / FCF	-20.65
Interest Coverage	-1.54

Financial Efficiency

Return on equity (ROE) is 0.86% and return on invested capital (ROIC) is -4.32%.

Return on Equity (ROE)	0.86%
Return on Assets (ROA)	-3.99%
Return on Invested Capital (ROIC)	-4.32%
Return on Capital Employed (ROCE)	-12.67%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	4.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.66% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.66%
50-Day Moving Average	11,279.00
200-Day Moving Average	9,132.20
Relative Strength Index (RSI)	27.42
Average Volume (20 Days)	222,713

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Solution had revenue of KRW 15.20 billion and earned 273.36 million in profits. Earnings per share was 11.32.

Revenue	15.20B
Gross Profit	9.57B
Operating Income	-4.34B
Pretax Income	273.36M
Net Income	273.36M
EBITDA	-2.16B
EBIT	-4.34B
Earnings Per Share (EPS)	11.32

Balance Sheet

The company has 12.09 billion in cash and 30.91 billion in debt, with a net cash position of -18.82 billion or -729.21 per share.

Cash & Cash Equivalents	12.09B
Total Debt	30.91B
Net Cash	-18.82B
Net Cash Per Share	-729.21
Equity (Book Value)	32.00B
Book Value Per Share	1,323.96
Working Capital	-14.80B

Cash Flow

In the last 12 months, operating cash flow was -1.31 billion and capital expenditures -184.98 million, giving a free cash flow of -1.50 billion.

Operating Cash Flow	-1.31B
Capital Expenditures	-184.98M
Depreciation & Amortization	2.18B
Net Borrowing	-926.93M
Free Cash Flow	-1.50B
FCF Per Share	-58.00

Margins

Gross margin is 62.95%, with operating and profit margins of -28.56% and 1.80%.

Gross Margin	62.95%
Operating Margin	-28.56%
Pretax Margin	1.80%
Profit Margin	1.80%
EBITDA Margin	-14.24%
EBIT Margin	-28.56%
FCF Margin	n/a

Dividends & Yields

Bio Solution does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.91%
Shareholder Yield	-3.91%
Earnings Yield	0.13%
FCF Yield	-0.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 27, 2025. It was a forward split with a ratio of 3.

Last Split Date	May 27, 2025
Split Type	Forward
Split Ratio	3

Scores

Bio Solution has an Altman Z-Score of 2.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.47
Piotroski F-Score	2